News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Seth Force, MD

Articles by Seth Force, MD

Proof of Efficacy for Adjuvant Treatment in Stage IB NSCLC: Searching for a Needle in a Haystack?

BySuresh S. Ramalingam, MD,Seth Force, MD,Fadlo R. Khuri, MD

April 30th 2008

Latest Updated Articles

Proof of Efficacy for Adjuvant Treatment in Stage IB NSCLC: Searching for a Needle in a Haystack?
April 30th 2008

Trending on CancerNetwork

TOP Trial: Chemo-Osimertinib in TP53-Mutant EGFR-Mutated NSCLC

How Are CELMoDs Reshaping Treatment in Multiple Myeloma?

Five Gastrointestinal Cancer Abstracts You May Have Missed at ESMO GI 2026

FLAURA2: Osimertinib Plus Chemo in EGFR-Mutant NSCLC

Access to Care and Drug Prices: Recent Department of Health and Human Services Guidance